SciBase Achieves 400,000 Nevisense Tests Sold Milestone
The company has reached a major sales milestone for its skin diagnostic device.
Stockholm , 07 Apr 2026 (Viralpressreleases.com) -
SciBase Holding AB, a developer of AI based diagnostic solutions for skin disorders, has announced a significant achievement. The company has now sold over 400,000 Nevisense tests around the world. This milestone highlights the growing adoption of their technology in dermatology practices.
Nevisense is the only FDA approved and CE marked non invasive diagnostic tool. Dermatologists use it to evaluate suspicious moles and assess a patient’s individual risk for melanoma. It provides more accurate and personalized insights at the point of care, which supports better clinical decision making for skin cancer detection.
While Nevisense is mainly used to detect skin cancer including melanoma and non melanoma skin cancer, interest in its ability to assess the skin barrier is growing. A new clinical study published after 2025 showed the device can predict atopic dermatitis in newborns. Several larger studies for this indication are already underway.
Pia Renaudin, SciBase CEO, noted that reaching another key milestone empowers clinicians. Each Nevisense test helps doctors make more informed and precise early detection decisions. This ultimately improves patient outcomes according to the CEO.
A key development for diagnosing other dermatological diseases is the 2025 collaboration with Castle Biosciences. This agreement opens exciting opportunities for new medical indications. The partnership is an important milestone as the company expands the use of Nevisense beyond skin cancer detection.
About SciBase
SciBase is a global medical technology company focused on early detection and prevention in dermatology. The company developed Nevisense, a point of care device using electrical impedance spectroscopy. Its goal is to reduce uncertainty in skin exams and lower healthcare costs by improving diagnostic accuracy. SciBase is based in Stockholm and listed on the Nordic Growth Market.Media Contacts
For further information, please contact: Pia Renaudin, CEO Phone: +46 73 206 98 02 Email: pia.renaudin@scibase.comCategory : Science, IT, AI & Technology
###